Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study Meeting Abstract


Authors: Andre, T.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D. M.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; De La Fouchardiere, C.; Rivera, F.; Elez, E.; Bendell, J. C.; Le, D. T.; Yoshino, T.; Yang, P.; Farooqui, M. Z. H.; Marinello, P.; Diaz, L. A.
Abstract Title: Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Keywords: 283-237-255130-540-543842421834169218212610111138092-3489238092-2918761
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 18 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-06-20
Language: English
ACCESSION: WOS:000572436700008
DOI: 10.1200/JCO.2020.38.18_suppl.LBA4
PROVIDER: wos
Notes: Meeting Abstract: LBA4 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luis Alberto Diaz
    148 Diaz